Negative Predictive Value of Drug ProvocationTests to Beta-lactams (NPVDPT)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02844712
Recruitment Status :
(End of the period of inclusion, NSN not achieved)
Patients with a complete drug allergy work-up to betalactam antibiotics were contacted (by mail) and asked to answer a questionnaire regarding the tolerance upon readministration of a negatively tested beta-lactam.
Condition or disease
Other: Evaluation of reexposure to a negatively tested betalactam
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
5 Years and older (Child, Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Elderly patients with at least 5 years at the time of consultation for allergy suspected allergy to beta-lactam antibiotics in the University Hospital of Montpellier and with a negative provocation test to a betalactam
The patient or the patient's legal representatives are not their opposition to participate in this study
The patient must be affiliated or beneficiary in a health insurance system
The patient is exclusion period determined by a previous study
The patient is under judicial protection, guardianship or curatorship
The patient or the patient's legal representatives do not read fluently the French language